An Evening With the Experts: Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Hear from the experts on how the latest clinical data inform the use of biomarkers to assess risk and selection of CDK4/6 inhibitor&ndash based therapy for patients with HR+/HER2- early breast cancer in these downloadable slides and on-demand webcast from a live CCO webinar.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly